Levofloxacin
Brand names: Tavanic
Levofloxacin is a fluoroquinolone antibacterial, the active L-isomer of ofloxacin, used for respiratory, urinary, skin and certain other infections when alternatives are unsuitable.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits the bacterial enzymes DNA gyrase and topoisomerase IV, blocking DNA replication, transcription and repair, leading to bacterial cell death.
Prescribing in practice
- MHRA advice restricts fluoroquinolones because of rare but disabling, potentially long-lasting or irreversible musculoskeletal and neurological effects, including tendon rupture, so they should be reserved for situations where other antibacterials cannot be used.
- It prolongs the QT interval and lowers the seizure threshold, warranting caution with other QT-prolonging drugs and in those at risk of convulsions.
- Absorption is reduced by antacids and iron, zinc or calcium products, which must be separated from the dose.
Monitoring
Review for tendon pain, neuropathy, neuropsychiatric symptoms and, where relevant, QT interval, stopping treatment at the first sign of serious adverse effects.
Counselling the patient
- Stop the antibiotic and seek advice if you develop tendon pain or swelling, numbness, or new mood or sleep changes.
- Separate indigestion remedies and iron, zinc or calcium supplements from your dose.
- Avoid excessive sun exposure and report any new joint or muscle problems.
Evidence & guidelines
Use is governed by MHRA and NICE guidance restricting fluoroquinolones to situations where other antibacterials are inappropriate.
Reference: MHRA Drug Safety Update 2019; NICE Antimicrobial Prescribing Guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia